Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment
Bell’s palsy is the common name for the inflammation of the cranial nerve VII. The peculiar geniculate ganglion inflammation is idiopathic and causes hemifacial paralysis. Patients who suffer from this paralysis may have their symptoms dissipate between 3 weeks and 3 months. For certain patients w...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rabia Yılmaz
2022-07-01
|
| Series: | Journal of Contemporary Medicine |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2141943 |
| _version_ | 1797860616139964416 |
|---|---|
| author | Abraham Melara Sathees Chandra |
| author_facet | Abraham Melara Sathees Chandra |
| author_sort | Abraham Melara |
| collection | DOAJ |
| description | Bell’s palsy is the common name for the inflammation of the cranial nerve VII. The peculiar geniculate ganglion inflammation is idiopathic and causes hemifacial paralysis. Patients who suffer from this paralysis may have their symptoms dissipate between 3 weeks and 3 months. For certain patients whose facial paralysis persist, botulinum toxin type- A might be an efficient treatment. Depending on the severity of the muscular palsy, different treatments can be offered including surgery, steroid, and anti-viral treatment as well as Botox. This review article’s purpose is to dive into the possible correlation of viral pathogens with the activation of the facial nerve inflammation, and how patients with Bell’s palsy can benefit from Botox type-A as treatment. |
| first_indexed | 2024-04-09T21:48:44Z |
| format | Article |
| id | doaj.art-608c09983015489da67809361260493d |
| institution | Directory Open Access Journal |
| issn | 2667-7180 |
| language | English |
| last_indexed | 2024-04-09T21:48:44Z |
| publishDate | 2022-07-01 |
| publisher | Rabia Yılmaz |
| record_format | Article |
| series | Journal of Contemporary Medicine |
| spelling | doaj.art-608c09983015489da67809361260493d2023-03-24T19:43:26ZengRabia YılmazJournal of Contemporary Medicine2667-71802022-07-0112457958310.16899/jcm.10390221809Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatmentAbraham Melara0Sathees Chandra1Barry UniversityBarry UniversityBell’s palsy is the common name for the inflammation of the cranial nerve VII. The peculiar geniculate ganglion inflammation is idiopathic and causes hemifacial paralysis. Patients who suffer from this paralysis may have their symptoms dissipate between 3 weeks and 3 months. For certain patients whose facial paralysis persist, botulinum toxin type- A might be an efficient treatment. Depending on the severity of the muscular palsy, different treatments can be offered including surgery, steroid, and anti-viral treatment as well as Botox. This review article’s purpose is to dive into the possible correlation of viral pathogens with the activation of the facial nerve inflammation, and how patients with Bell’s palsy can benefit from Botox type-A as treatment.https://dergipark.org.tr/tr/download/article-file/2141943bell paralizibotulinum toksin tip abotoksfasiyal sinirkas felcibell’s palsybotulinum toxin type abotoxfacial nervemuscular paralysis |
| spellingShingle | Abraham Melara Sathees Chandra Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment Journal of Contemporary Medicine bell paralizi botulinum toksin tip a botoks fasiyal sinir kas felci bell’s palsy botulinum toxin type a botox facial nerve muscular paralysis |
| title | Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment |
| title_full | Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment |
| title_fullStr | Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment |
| title_full_unstemmed | Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment |
| title_short | Bell’s palsy’s viral pathogenicity and the use of botulinum toxin type A as treatment |
| title_sort | bell s palsy s viral pathogenicity and the use of botulinum toxin type a as treatment |
| topic | bell paralizi botulinum toksin tip a botoks fasiyal sinir kas felci bell’s palsy botulinum toxin type a botox facial nerve muscular paralysis |
| url | https://dergipark.org.tr/tr/download/article-file/2141943 |
| work_keys_str_mv | AT abrahammelara bellspalsysviralpathogenicityandtheuseofbotulinumtoxintypeaastreatment AT satheeschandra bellspalsysviralpathogenicityandtheuseofbotulinumtoxintypeaastreatment |